AMD3100 TO MOBILIZE PERIPHERAL BLOOD STEM CELLS

点击翻译按钮获取中文摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Determine if AMD3100, given with a G-CSF mobilizing regimen is generally safe and well tolerated. Determine if AMD3100, given with a G-CSF mobilizing regimen will increase the number of peripheral stem cells collected for transplantation.